AGP Executive Report
Last update: 4 hours agoMedicinal Cannabis Market Moves (Australia): Vitura Health (ASX:VIT) is drawing attention for staying profitable with an asset-light digital marketplace model that scales with transactions, not farms. Distribution Expansion (Australia): Cann Group (ASX:CAN) is widening pharmacy distribution via national chain arrangements, shifting product access beyond specialist dispensaries. Balance-Sheet Focus (Australia/Europe): Althea Group (ASX:AGH) trimmed its offshore footprint by divesting a UK unit, refocusing on stronger revenue markets like Germany. Export-Led Growth (Australia/Europe): Little Green Pharma (ASX:LGP) is edging up as European shipment volumes build, with its early Australia-to-Europe compliance pathway still a key differentiator. Drug Enforcement (Nigeria): NDLEA arrested a Lagos marble dealer with 1.55kg of cocaine hidden in luggage walls/railings and says he sold assets to fund the deal; separate raids recovered massive codeine syrup and other controlled substances. Aviation Safety Watch (India): Reports of an Air India pilot testing positive for cannabis are under scrutiny, with no confirmed link yet to a recent altitude incident. Cannabis & Community Tensions (UK): A Wiltshire campsite sought a licence despite neighbours citing noise and alleged cannabis-related concerns at events. Tourism/Experience (Australia): Sydney’s St James tunnels are set to open to the public year-round, adding another “experience-led” draw to the city.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.